CD255 (TWEAK), Human Antibody from MILTENYI BIOTEC B.V. & Co. KG
Search, find, compare suppliers for anti-CD255 (TWEAK), Human antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CD255 (TWEAK), Human |
| Clone | CARL-1 |
| Host Species | Mouse |
| Reactive Species | human |
| Isotype | IgG3κ |
| Format | biotin conjugate |
| Size | 100 tests in 1 mL |
| Concentration | 1:11 |
| Applications | Flow cytometry |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | CD255 (TWEAK) Antibody, anti-human, Biotin. Clone CARL-1 reacts with the type II transmembrane protein CD255, also known as TWEAK, belonging to the TNF superfamily. It exists as membrane-bound and secreted form and is expressed on most tissues but not or weakly on hematopoietic lineage lines. TWEAK interacts with its receptor APO-3, which promotes inerleukin 8 (IL-8) secretion, activation of NF-κB, and endothelial cell proliferation and apoptosis. |
| Immunogen | n/a |
| Other Names | TNFSF12, APO3L, Dr3lg, TWEAK |
| Gene, Accession # | Gene ID: 8742 |
| Catalog # | 130-098-926 |
| Price | $264 |
| Order / More Info | CD255 (TWEAK), Human Antibody from MILTENYI BIOTEC B.V. & Co. KG |
| Product Specific References | Kaplan, M. J. et al. (2000) TRAIL (Apo2 Ligand) and TWEAK (Apo3 Ligand) mediate CD4+ T cell killing of antigen-presenting macrophages. J Immunol 164: 2897- 2904. | Chicheportiche, Y. et al. (1997) TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J. Biol. Chem. 272: 32401 -32410. | Lynch, C. N. et al. (1999) TWEAK induces angiogenesis and proliferation of endothelial cells. J. Biol. Chem. 274: 8455-8459. |
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-StraÃe 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197
macs@miltenyibiotec.de
https://www.miltenyibiotec.com
Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies